Journal of Peking University(Health Sciences) ›› 2016, Vol. 48 ›› Issue (3): 392-397. doi: 10.3969/j.issn.1671-167X.2016.03.003

• Article • Previous Articles     Next Articles

Immunomodulatory effect of oyster peptide on immunosuppressed mice

XU Dan1, LIN Feng2, ZHU Xiao-yu1, LIU Wen-ying2, CHEN Xiao-wen1, FENG Jin-qiu1, FAN Ai-qin1, CAI Mu-yi2△, XU Ya-jun1△   

  1. (1. Department of Nutrition and Food Hygiene, Peking University School of Public Health, Beijing 100191, China; 2. Beijing Engineering Research Center of Protein and Functional Peptides, China National Research Institute of Food and Fermentation Industries, Beijing 100015, China)
  • Online:2016-06-18 Published:2016-06-18
  • Contact: CAI Mu-yi, XU Ya-jun E-mail:caimuyi@139.com, xuyajun@bjmu.edu.cn
  • Supported by:

    Supported by the National Science & Technology Pillar Program During the 12th Five-Year Plan (2012BAD33B04-02) and the National High Technology Research and Development Program of China (863 Program) (2013AA102205-02)

Abstract:

Objective: To evaluate the immunomodulating effect of oyster peptide on immunosuppressed mice. Methods: ICR mice injected with cyclophosphamide (CTX) were adopted as the module group, with mice without treatment as the control group, and different dosages of oyster peptide (0.5 g/kg, 1.0 g/kg, and 2.0 g/kg) were given to the low, middle, and high groups for 15 days. The body weight, spleen, and thymus weight of the mice, structures under the microscope of the immune organs, numbers of white blood cells, ratios of T lymphocyte subsets, immune cytokines and numbers of nuclear cells, and DNA content in bone marrow were all assessed. Results: Compared with the control group, the structures of thymus and spleen of the mice in the CTX group appeared obscure and shrunk when observed under microscope, the number of their white blood cells declined (P=0.04), the proportion of their CD3+T cells in peripheral blood declined (P=0.003), the proportion of their CD8+T cells in peripheral blood declined (P=0.002), the concentration of their IL-5 in peripheral blood significantly increased (P<0.01), the concentration of their nucleated cells and DNA density in bone marrow decreased (P=0.04, P<0.01). Oyster could improve the structures of thymus and spleen of the immunosuppressed mice. Compared with the CTX group, the number of white blood cells in 2.0 g/kg group increased (P=0.003), the proportion of CD3+T cells in peripheral blood in 1.0 g/kg group (P=0.04) and 2.0 g/kg group (P=0.02) increased, the proportion of CD8+T cells in peripheral blood in 2.0 g/kg group increased (P=0.002), the concentration of IL-5 in peripheral blood in all the oyster treated groups increased (P<0.01 in 0.5 g/kg, 1.0 g/kg, and 2.0 g/kg groups), the concentration of IL-17 in peripheral blood in 2.0 g/kg group decreased (P=0.03), the concentration of nucleated cells in bone marrow of all the oyster treated groups increased (0.5 g/kg vs. CTX, P=0.04; 1.0 g/kg vs. CTX, P=0.02; 2.0 g/kg vs. CTX P=0.01), the DNA content in bone marrow of all the oyster treated groups increased (P<0.01 in the 0.5 g/kg, 1.0 g/kg, and 2.0 g/kg groups). Conclusion: Oyster peptide could improve the structures of immune organs of the CTX-induced immunosuppressed mice, recover the imbalances of T lymphocyte subsets, improve the immune cytokines and increase numbers of nucleated cells and DNA content in bone marrow, thus improving the immunologic function.

Key words: Peptide, Ostreidae, Cyclophosphamid, Immunoregulation, Bioactive peptides

CLC Number: 

  • R151.3
[1] Duo YANG,Xin-na ZHOU,Shuo WANG,Xiao-li WANG,Yan-hua YUAN,Hua-bin YANG,Hui-zhen GENG,Bing PENG,Zi-bo LI,Bin LI,Jun REN. Assessment of lymphocytic function in vitro stimulated by specific tumor polypeptide combined with dendritic cells [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1094-1098.
[2] Lu ZHANG,Xiao-hong HU,Qing-wen WANG,Yue-ming CAI,Jin-xia ZHAO,Xiang-yuan LIU. Population distribution and clinical characteristics in rheumatoid arthritis patients with cervical spine instability [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1034-1039.
[3] Jing-feng ZHANG,Xiu-ling YE,Meng DUAN,Xiao-li ZHOU,Zhong-qiang YAO,Jin-xia ZHAO. Clinical and laboratory characteristics of rheumatoid arthritis with positive antinuclear antibody [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1023-1028.
[4] Li-yi DAI,Dan-dan GONG,Jin-xia ZHAO. Clinical characteristics of psoriatic arthritis with positive rheumatoid factor or anti-cyclic citrullinated peptide antibody [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1008-1013.
[5] GAN Hong-quan, WANG Qian, ZHANG Hui, LIU Xin, DENG Hua-min, SONG Hui-ping, WANG ZHi-qiang, LI Qi-jia. Effects of RGD peptides-grafted porous tantalum on morphological change of MG63 osteoblasts-tantalum conjunctive interface and expression of osteogenesis factors [J]. Journal of Peking University(Health Sciences), 2018, 50(1): 176-182.
[6] LIU Jing-wei, LU Xu, YANG Zhao-min, DENG Li-juan, YANG Lin. Immune effects of specific CTLs response induced by dendritic cells pulsed with NY-ESO-1 peptide [J]. Journal of Peking University(Health Sciences), 2017, 49(5): 840-846.
[7] LI Zhi-xia, WU Shan-shan, YANG Zhi-rong, ZHAN Si-yan, SUN Feng. Impact of glucagon-like peptide-1 receptor agonists on nasopharyngitis and upper respiratory tract infection among patients with type 2 diabetes: a network meta-analysis [J]. Journal of Peking University(Health Sciences), 2016, 48(3): 454-459.
[8] LIU Yuan, WANG Yong-Fu, WANG Kai-Li, 吕Feng-Feng . Prevalence and significance of immunoglobulin G-anti-cyclic citrullinated peptide antibodies in primary Sjögren’s syndrome patients [J]. Journal of Peking University(Health Sciences), 2014, 46(3): 478-482.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Author. English Title Test[J]. Journal of Peking University(Health Sciences), 2010, 42(1): 1 -10 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 188 -191 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 376 -379 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 459 -462 .
[5] . [J]. Journal of Peking University(Health Sciences), 2010, 42(1): 82 -84 .
[6] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 319 -322 .
[7] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 333 -336 .
[8] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 337 -340 .
[9] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 225 -328 .
[10] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 346 -350 .